The UCLA Polycystic Kidney Disease (PKD) Program is dedicated to providing the highest quality of patient care, performing cutting-edge research, and educating patients and healthcare professionals about the latest advances. UCLA offers comprehensive care for Polycystic Kidney Disease (PKD) for both autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) through a team approach that includes collaboration among specialists in nephrology, urology, radiology, transplant, dialysis, hepatology, neurology, cardiology, dermatology, genetics, OB/GYN, pain, infectious disease, nutrition, social work, patient advocacy, psychiatry, and pediatrics. UCLA is currently following over 100 ADPKD patients, 10 ARPKD patients, and 10 pediatric PKD patients.
There is a wide array of services that the UCLA PKD Program provides, including kidney transplant and donation, nephrectomy, hemodialysis, home hemodialysis, peritoneal dialysis, genetic testing and counseling, aneurysm screening, dietary counseling, and mental health counseling.
The UCLA PKD Program is committed to ongoing research and clinical studies, including basic science, applied clinical science, outcomes, and evidence-based research, in the mission to develop new treatments and cures for polycystic kidney disease. For information about current clinical trials, please contact [email protected] or 310-954-2692.
For more information on PKD, please visit:
PKD Webinar presented by Dr. Anjay Rastogi, Director of the UCLA PKD Program:
Symposium: Frontiers in Autosomal Dominant Polycystic Kidney Disease (ADPKD):
Learn how you can support the PKD Program by visiting giving.ucla.edu/kidney.